Current scientific investigations focus on metabolic regulation, receptor signalling, energy metabolism, peptide pharmacology, and molecular pathway modelling under controlled laboratory conditions
This ensures everyone gets the support they need to reach their weight loss goals
GLP-1R agonists effects on cardiovascular events The first pieces of evidence of the potential clinical benefit of GLP-1 agonists have emerged recently, pointing to a decrease of major adverse cardiovascular and cerebrovascular events (MACCE) including stroke, MI, cardiac mortality, acute coronary syndrome, and revascularization procedures

Discuss: Your target weight loss and timeframe How weight loss might affect your inflammatory condition Whether weight management could potentially reduce disease activity or medication requirements Realistic expectations about side effects and how these will be managed Monitoring plans need to be agreed upon, including: Frequency of follow-up appointments Which healthcare professional will oversee each aspect of your care What symptoms should trigger urgent contact Blood test schedules and other investigations Practical administration questions should be addressed: Optimal timing for each injection Injection site rotation strategies Storage requirements for both medications What to do if you miss a dose of either medicine Travel considerations if you need to transport injectable medications Pregnancy planning is crucial, as both medications have implications for pregnancy and breastfeeding